Screening Tools

Lead authors: Jennifer McNeely, MD, MS,1 and Angeline Adam, MD,1 with the Substance Use Guidelines Committee; October 2020

Screening Tools

Successful substance use screening relies on accurate patient self-report. Although urine toxicology, measures of blood alcohol level, or other laboratory testing may detect the presence of substances used very recently, (typically hours or ≤4 days after the last use), these tests are not appropriate for identifying unhealthy use, which may be intermittent and occur over time [Bosker and Huestis 2009; Cone and Huestis 2007; Verstraete 2004]. Laboratory screening tests for alcohol and drugs do not provide information about the severity or consequences of use, and thus provide less information than questionnaires. 

There is no reliable biomarker with sufficient sensitivity and specificity to identify the range of drinking behaviors that constitute unhealthy alcohol use [Afshar, et al. 2017; Jarvis, et al. 2017; Jatlow, et al. 2014; Stewart, et al. 2014; Verstraete 2004; Neumann and Spies 2003]. For drug use, urine, saliva, and blood testing are not recommended as replacements for questionnaire-based screening because laboratory tests have a brief window of detection (typically 1 to 4 days) [Bosker and Huestis 2009; Cone and Huestis 2007; Verstraete 2004]. Although hair testing has a more extended detection period, the cost and lack of reliability for detecting occasional drug use decrease its utility in primary care [Verstraete 2004].

Table 1: Recommended Validated Tools for Use in Medical Settings to Screen for Alcohol and Drug Use in Adults
Tool [a] Substance(s) Included No. of Items, Approximate Time Required to Complete, and Format

AUDIT-C (Alcohol Use Disorders Identification Test–Concise)
[Bradley, et al. 2007; Bush, et al. 1998]

  • Available in languages other than English
  • Alcohol
  • 3 items; 1 to 2 minutes
  • Interviewer or self-administered via electronic app or on paper
SISQ-Alc (Single-Item Screening Questions for Alcohol)
[McNeely(b), et al. 2015; Smith, et al. 2009]
  • Alcohol
  • 1 item; 1 minute
  • Interviewer or self-administered via electronic app or on paper

SISQ-Drug (Single-Item Screening Questions for Drug Use)
[McNeely(b), et al. 2015; Smith, et al. 2010]

  • Prescription drugs
  • Other drugs
  • 1 item; 1 minute
  • Interviewer– or self-administered via electronic app or on paper
SoDU (Screen of Drug Use)
[Tiet, et al. 2015]
  • Prescription drugs
  • Other drugs
  • 2 items; 1 minute
  • Interviewer
SUBS (Substance Use Brief Screen)
[McNeely and Saitz 2015]
  • Tobacco
  • Alcohol
  • Prescription drugs
  • Other drugs
  • 4 items; 2 minutes
  • Interviewer or self-administered via electronic app or on paper
TAPS-1 (Tobacco, Alcohol, Prescription Medication, and Other Substance Use)
[Gryczynski, et al. 2017]
  • Tobacco
  • Alcohol
  • Prescription drugs
  • Other drugs
  • 4 items; 2 minutes
  • Interviewer or self-administered via electronic app


  1. For information on the sensitivity and specificity of tools for drug screening, please see the U.S. Preventive Services Task Force (USPSTF) evidence review Unhealthy Drug Use: Screening; for information on the sensitivity and specificity for alcohol screening, see Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: An Updated Systematic Review for the USPSTF.
  • Whenever possible, it is best to have patients self-administer the screening and assessment questionnaires rather than having the clinician or staff ask the questions. In general, self-administered screening facilitates more accurate reporting of stigmatized behavior, such as substance use [McNeely, et al. 2018; Spear, et al. 2016; Williams, et al. 2015; Bradley, et al. 2011; Wight, et al. 2000; Tourangeau and Smith 1996].

An optimal screening instrument will quickly and accurately identify individuals with the full spectrum of unhealthy use, fit into the existing clinical workflow, and have flexible administration options (i.e., self- or interviewer-administered). To facilitate patient report of substance use, the language used in any screening tool should be clear and nonjudgmental. Drug screening should capture nonmedical prescription drug use and illicit drug use. Table 1: Recommended Validated Tools for Use in Medical Settings to Screen for Alcohol and Drug Use in Adults, above, lists recommended substance use screening tools.

The briefest approach to screening may be to use the Single-Item Screening Questions (SISQ) for alcohol or drug use (SISQ-Alc and -Drug). SISQ tools are validated for interviewer administration or self-administration and have good sensitivity and specificity. A positive response on SISQ tools identifies unhealthy use in the past year but does not indicate the level of risk. Both the Substance Use Brief Screen (SUBS) and the first section of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS-1) tool elicit information about use of tobacco, alcohol, illicit drugs, and nonmedical prescription drugs through a single 4-item instrument. Like the SISQ-Alc and -Drug, the SUBS and TAPS-1 tools screen for any use in the past year, and a positive response indicates unhealthy use but does not identify level of risk.

In some circumstances, the purpose of screening may be to diagnose substance use disorder rather than identify unhealthy drug use. For example, if the clinical setting cannot offer early intervention or preventive care, screening may be used to identify individuals in need of referral to addiction treatment. In such cases, the Screen of Drug Use (SoDU) tool, which specifically identifies drug use disorders, may be used. The SoDU was validated using Diagnostic and Statistical Manual of Mental Disorders–IV (DSM-IV) criteria, and a positive screen corresponds to a DSM-IV diagnosis of “drug abuse or dependence.”  

Alcohol: The briefest alcohol screening questionnaires (SISQ-Alc, TAPS-1, SUBS) use a single question about binge drinking in the past year to identify unhealthy alcohol use. Although it is possible for patients to use more alcohol than the recommended limits in the U.S. Department of Health and Human Services and Department of Agriculture Dietary Guidelines (14 drinks/week for men ≤65 years old, 7 drinks/week for women and men ≥65 years old), even in the absence of binge drinking, validation studies have demonstrated good sensitivity [NIAAA 2016; DHHS 2015]. The 3-item Alcohol Use Disorders Identification Test–Concise (AUDIT-C) is a widely used and recommended brief screening tool for alcohol use in medical settings [Moyer 2013; Frank, et al. 2008; Bradley, et al. 2007; Reinert and Allen 2007; Bradley, et al. 2003; Bush, et al. 1998]. Unlike the other brief screening tools, the AUDIT-C identifies the level of risk to patients with problem use and high-risk use. The AUDIT-C does not screen for tobacco or drugs.

Tobacco: Tobacco use is incorporated into some of the brief screening instruments (SUBS, TAPS-1) included in Table 1: Recommended Validated Tools for Use in Medical Settings to Screen for Alcohol and Drug Use in Adults, above. The accuracy of SUBS and TAPS-1 tools for identifying tobacco use is high, with a sensitivity of 98% and a specificity ranging from 80% to 96% [Gryczynski, et al. 2017; McNeely(a), et al. 2015]. Use of a single instrument that concurrently screens for tobacco and alcohol use will streamline the screening process.

Drugs: Screening for drug use can be performed with the SISQ-Drug, SUBS, or TAPS-1 tools, all of which perform well in validation studies of adults in primary care settings [Gryczynski, et al. 2017; McNeely(a), et al. 2016; McNeely(a), et al. 2015; McNeely(b), et al. 2015]. With changes in the legal status of cannabis and shifting attitudes toward cannabis use, clinics should provide patients and staff with clear instructions about reporting cannabis use on questionnaires that categorize cannabis as an illicit drug [Lapham, et al. 2017]. In states where cannabis is legal, it may be best to ask about its use separately from illicit drugs [Sayre, et al. 2020].

Section on Tobacco, Alcohol, and Drug Use, Dept. of Population Health, NYU Grossman School of Medicine, New York, NY


Afshar M, Burnham EL, Joyce C, et al. Cut-point levels of phosphatidylethanol to identify alcohol misuse in a mixed cohort including critically ill patients. Alcohol Clin Exp Res 2017;41(10):1745-1753. [PMID: 28792620

Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem 2009;55(11):1910-1931. [PMID: 19745062

Bradley KA, Bush KR, Epler AJ, et al. Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med 2003;163(7):821-829. [PMID: 12695273

Bradley KA, DeBenedetti AF, Volk RJ, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007;31(7):1208-1217. [PMID: 17451397

Bradley KA, Lapham GT, Hawkins EJ, et al. Quality concerns with routine alcohol screening in VA clinical settings. J Gen Intern Med 2011;26(3):299-306. [PMID: 20859699

Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158(16):1789-1795. [PMID: 9738608

Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci 2007;1098:51-103. [PMID: 17332074

DHHS. Dietary guidelines 2015-2020. Appendix 9. Alcohol. 2015 Dec. [accessed 2020 Jun 30]

Frank D, DeBenedetti AF, Volk RJ, et al. Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic groups. J Gen Intern Med 2008;23(6):781-787. [PMID: 18421511

Gryczynski J, McNeely J, Wu LT, et al. Validation of the TAPS-1: A four-item screening tool to identify unhealthy substance use in primary care. J Gen Intern Med 2017;32(9):990-996. [PMID: 28550609

Jarvis M, Williams J, Hurford M, et al. Appropriate use of drug testing in clinical addiction medicine. J Addict Med 2017;11(3):163-173. [PMID: 28557958

Jatlow PI, Agro A, Wu R, et al. Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res 2014;38(7):2056-2065. [PMID: 24773137

Lapham GT, Lee AK, Caldeiro RM, et al. Frequency of cannabis use among primary care patients in Washington State. J Am Board Fam Med 2017;30(6):795-805. [PMID: 29180554

McNeely(b) J, Cleland CM, Strauss SM, et al. Validation of Self-Administered Single-Item Screening Questions (SISQs) for unhealthy alcohol and drug use in primary care patients. J Gen Intern Med 2015;30(12):1757-1764. [PMID: 25986138

McNeely J, Kumar PC, Rieckmann T, et al. Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff. Addict Sci Clin Pract 2018;13(1):8. [PMID: 29628018

McNeely J, Saitz R. Appropriate screening for substance use vs disorder. JAMA Intern Med 2015;175(12):1997-1998. [PMID: 26641355

McNeely(a) J, Strauss SM, Saitz R, et al. A brief patient self-administered substance use screening tool for primary care: Two-site validation study of the Substance Use Brief Screen (SUBS). Am J Med 2015;128(7):784.e789-719. [PMID: 25770031

McNeely J, Wu LT, Subramaniam G, et al. Performance of the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool for substance use screening in primary care patients. Ann Intern Med 2016;165(10):690-699. [PMID: 27595276

Moyer VA. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;159(3):210-218. [PMID: 23698791

Neumann T, Spies C. Use of biomarkers for alcohol use disorders in clinical practice. Addiction 2003;98 Suppl 2:81-91. [PMID: 14984245

NIAAA. Helping patients who drink too much: A clinician’s guide. 2016 Jul. [accessed 2020 May 6]

Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test: an update of research findings. Alcohol Clin Exp Res 2007;31(2):185-199. [PMID: 17250609

Sayre M, Lapham GT, Lee AK, et al. Routine assessment of symptoms of substance use disorders in primary care: Prevalence and severity of reported symptoms. J Gen Intern Med 2020;35(4):1111-1119. [PMID: 31974903

Smith PC, Schmidt SM, Allensworth-Davies D, et al. Primary care validation of a single-question alcohol screening test. J Gen Intern Med 2009;24(7):783-788. [PMID: 19247718

Smith PC, Schmidt SM, Allensworth-Davies D, et al. A single-question screening test for drug use in primary care. Arch Intern Med 2010;170(13):1155-1160. [PMID: 20625025

Spear SE, Shedlin M, Gilberti B, et al. Feasibility and acceptability of an audio computer-assisted self-interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients. Subst Abus 2016;37(2):299-305. [PMID: 26158798

Stewart SH, Koch DG, Willner IR, et al. Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol Clin Exp Res 2014;38(6):1706-1711. [PMID: 24848614

Tiet QQ, Leyva YE, Moos RH, et al. Screen of drug use: Diagnostic accuracy of a new brief tool for primary care. JAMA Intern Med 2015;175(8):1371-1377. [PMID: 26075352

Tourangeau R, Smith TW. Asking sensitive questions: The impact of data collection mode, question format, and question context. Publ Opin Q 1996;60(2):275-304.

Verstraete AG. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 2004;26(2):200-205. [PMID: 15228165

Wight RG, Rotheram-Borus MJ, Klosinski L, et al. Screening for transmission behaviors among HIV-infected adults. AIDS Educ Prev 2000;12(5):431-441. [PMID: 11063062

Williams EC, Achtmeyer CE, Thomas RM, et al. Factors underlying quality problems with alcohol screening prompted by a clinical reminder in primary care: A multi-site qualitative study. J Gen Intern Med 2015;30(8):1125-1132. [PMID: 25731916